ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the Company), a developer of innovative treatment programs for substance use and related...
ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire ” BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of innovative treatment programs for substance abuse and...
ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire “ BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of innovative treatment programs for substance use and related...
ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire “ BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of innovative treatment programs for substance abuse and...
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire “ BioCorRx Inc. (OTCQB: BICX) (the œCompany), a developer and provider of innovative treatment programs for substance abuse and...
ANAHEIM, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire “ BioCorRx Inc. (OTCQB: BICX) (the œCompany), a developer and provider of innovative treatment programs for substance abuse and...
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients and Address Public Health Crisis ANAHEIM, CA, Aug. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire...
On Track to Meet 2023 Regulatory Milestones ANAHEIM, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire “ BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of innovative treatment programs for substance abuse and...
Revenue Increases 97% ANAHEIM, CA, May 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for...